194 related articles for article (PubMed ID: 4045840)
1. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
[TBL] [Abstract][Full Text] [Related]
2. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
[TBL] [Abstract][Full Text] [Related]
3. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of amyloid-enhancing factor.
Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
[TBL] [Abstract][Full Text] [Related]
5. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
Sørby R; Espenes A; Landsverk T; Westermark G
Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
[TBL] [Abstract][Full Text] [Related]
6. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
7. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
Snow AD; Kisilevsky R
Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
[TBL] [Abstract][Full Text] [Related]
8. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
[TBL] [Abstract][Full Text] [Related]
9. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist.
Grehan S; Herbert J; Whitehead AS
Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate inhibits reactive amyloidosis in mice.
Murai T; Yamada T; Miida T; Arai K; Endo N; Hanyu T
Arthritis Rheum; 2002 Jun; 46(6):1683-8. PubMed ID: 12115201
[TBL] [Abstract][Full Text] [Related]
12. Amyloid enhancing factor is produced by rats and amyloid-resistant CE/J mice.
Gonnerman WA; Kandel R; Cathcart ES
Lab Invest; 1996 Jan; 74(1):259-64. PubMed ID: 8569190
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
[TBL] [Abstract][Full Text] [Related]
14. Experimental AA amyloidosis in mice is inhibited by treatment with triptolide, a purified traditional Chinese medicine.
Cui D; Hoshii Y; Kawano H; Sugiyama S; Gondo T; Liu Y; Ishihara T
Int Immunopharmacol; 2007 Sep; 7(9):1232-40. PubMed ID: 17630202
[TBL] [Abstract][Full Text] [Related]
15. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
Shirahama T; Miura K; Ju ST; Kisilevsky R; Gruys E; Cohen AS
Lab Invest; 1990 Jan; 62(1):61-8. PubMed ID: 2296158
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy.
Kisilevsky R; Boudreau L
Lab Invest; 1983 Jan; 48(1):53-9. PubMed ID: 6823091
[TBL] [Abstract][Full Text] [Related]
17. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin: its potential significance in murine AA amyloidogenesis.
Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
[TBL] [Abstract][Full Text] [Related]
19. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
[TBL] [Abstract][Full Text] [Related]
20. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
Ailles L; Kisilevsky R; Young ID
Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
